⌘K

Home/Filings/4/0001179110-18-012858

4//SEC Filing

MILLIGAN DAVID V 4

Accession 0001179110-18-012858

CIK 0001157601other

View on SEC.gov Company Profile

Filed

Nov 13, 7:00 PM ET

Accepted

Nov 14, 6:43 PM ET

Size

6.6 KB

Accession

0001179110-18-012858

Insider Transaction Report

Form 4

Period: 2018-11-14

MADRIGAL PHARMACEUTICALS, INC.MDGL

MILLIGAN DAVID V

Director

Transactions

Exercise/Conversion
Common Stock
2018-11-14$16.46/sh+10,000$164,600→ 30,000 total
Exercise/Conversion
Stock Option (Right to Buy)
2018-11-14−10,000→ 0 total
Exercise: $16.46From: 2018-06-29Exp: 2027-06-29→ Common Stock (10,000 underlying)

Documents

1 file

4
edgar.xmlPrimary
FORM 4 -

Issuer

MADRIGAL PHARMACEUTICALS, INC.

CIK 0001157601

Entity typeother

Related Parties

1

filerCIK 0001222252

Filing Metadata

Form type: 4
Filed: Nov 13, 7:00 PM ET
Accepted: Nov 14, 6:43 PM ET
Size: 6.6 KB

View on SEC.gov